vs
Side-by-side financial comparison of Sachem Capital Corp. (SACH) and TriSalus Life Sciences, Inc. (TLSI). Click either name above to swap in a different company.
TriSalus Life Sciences, Inc. is the larger business by last-quarter revenue ($13.2M vs $12.0M, roughly 1.1× Sachem Capital Corp.). Sachem Capital Corp. runs the higher net margin — 8.3% vs -73.9%, a 82.2% gap on every dollar of revenue. On growth, TriSalus Life Sciences, Inc. posted the faster year-over-year revenue change (59.8% vs -18.8%). Over the past eight quarters, TriSalus Life Sciences, Inc.'s revenue compounded faster (43.0% CAGR vs -13.4%).
Sachem Capital Corp.SACHEarnings & Financial Report
Sachem Head Capital Management is an American value-oriented investment management firm based in New York City, managed by Scott Ferguson.
TriSalus Life Sciences, Inc. is a clinical-stage biotechnology company focused on advancing immuno-oncology and interventional oncology solutions. It develops proprietary targeted drug delivery technologies designed to improve treatment efficacy for patients with liver, pancreatic and other hard-to-treat solid tumors, primarily operating in North American markets via partnerships with clinical care and research institutions.
SACH vs TLSI — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $12.0M | $13.2M |
| Net Profit | $997.0K | $-9.8M |
| Gross Margin | — | 86.7% |
| Operating Margin | -3.1% | -24.8% |
| Net Margin | 8.3% | -73.9% |
| Revenue YoY | -18.8% | 59.8% |
| Net Profit YoY | 119.7% | 3.5% |
| EPS (diluted) | $0.00 | $-0.22 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $13.2M | ||
| Q3 25 | $12.0M | $11.6M | ||
| Q2 25 | $10.8M | $11.2M | ||
| Q1 25 | $11.4M | $9.2M | ||
| Q4 24 | $10.8M | $8.3M | ||
| Q3 24 | $14.8M | $7.3M | ||
| Q2 24 | $15.1M | $7.4M | ||
| Q1 24 | $16.8M | $6.5M |
| Q4 25 | — | $-9.8M | ||
| Q3 25 | $997.0K | $-10.8M | ||
| Q2 25 | $1.9M | $-8.3M | ||
| Q1 25 | $904.0K | $-10.4M | ||
| Q4 24 | $-36.1M | $-10.1M | ||
| Q3 24 | $-5.1M | $-2.4M | ||
| Q2 24 | $-3.1M | $-4.3M | ||
| Q1 24 | $4.7M | $-13.2M |
| Q4 25 | — | 86.7% | ||
| Q3 25 | — | 83.5% | ||
| Q2 25 | — | 83.9% | ||
| Q1 25 | — | 83.7% | ||
| Q4 24 | — | 85.3% | ||
| Q3 24 | — | 86.3% | ||
| Q2 24 | — | 87.6% | ||
| Q1 24 | — | 85.0% |
| Q4 25 | — | -24.8% | ||
| Q3 25 | -3.1% | -77.9% | ||
| Q2 25 | 9.9% | -65.4% | ||
| Q1 25 | 9.0% | -79.9% | ||
| Q4 24 | -131.1% | -91.8% | ||
| Q3 24 | -32.6% | -118.9% | ||
| Q2 24 | -20.6% | -111.0% | ||
| Q1 24 | 25.4% | -180.8% |
| Q4 25 | — | -73.9% | ||
| Q3 25 | 8.3% | -93.5% | ||
| Q2 25 | 17.5% | -73.9% | ||
| Q1 25 | 7.9% | -113.2% | ||
| Q4 24 | -335.6% | -122.4% | ||
| Q3 24 | -34.2% | -32.6% | ||
| Q2 24 | -20.2% | -58.8% | ||
| Q1 24 | 27.8% | -204.5% |
| Q4 25 | — | $-0.22 | ||
| Q3 25 | $0.00 | $-0.96 | ||
| Q2 25 | $0.02 | $-0.27 | ||
| Q1 25 | $0.00 | $-0.39 | ||
| Q4 24 | $-0.79 | $-0.38 | ||
| Q3 24 | $-0.13 | $-0.12 | ||
| Q2 24 | $-0.09 | $-0.21 | ||
| Q1 24 | $0.08 | $-0.60 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $12.6M | $20.4M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $175.6M | $-33.9M |
| Total Assets | $484.4M | $35.3M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $20.4M | ||
| Q3 25 | $12.6M | $22.7M | ||
| Q2 25 | $23.5M | $26.5M | ||
| Q1 25 | $25.8M | $13.0M | ||
| Q4 24 | $19.6M | $8.5M | ||
| Q3 24 | $7.4M | $11.3M | ||
| Q2 24 | $12.4M | $16.5M | ||
| Q1 24 | $56.8M | $4.0M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $230.2M | — | ||
| Q4 24 | $230.2M | — | ||
| Q3 24 | $264.7M | — | ||
| Q2 24 | $264.7M | — | ||
| Q1 24 | $288.4M | — |
| Q4 25 | — | $-33.9M | ||
| Q3 25 | $175.6M | $-26.7M | ||
| Q2 25 | $177.9M | $-19.4M | ||
| Q1 25 | $179.3M | $-34.4M | ||
| Q4 24 | $181.7M | $-25.9M | ||
| Q3 24 | $220.6M | $-20.4M | ||
| Q2 24 | $230.2M | $-25.3M | ||
| Q1 24 | $237.4M | $-36.0M |
| Q4 25 | — | $35.3M | ||
| Q3 25 | $484.4M | $36.5M | ||
| Q2 25 | $501.8M | $41.3M | ||
| Q1 25 | $491.4M | $28.6M | ||
| Q4 24 | $492.0M | $24.0M | ||
| Q3 24 | $555.5M | $27.5M | ||
| Q2 24 | $586.3M | $32.4M | ||
| Q1 24 | $626.5M | $17.9M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 1.28× | — | ||
| Q4 24 | 1.27× | — | ||
| Q3 24 | 1.20× | — | ||
| Q2 24 | 1.15× | — | ||
| Q1 24 | 1.21× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $4.9M | $-2.5M |
| Free Cash FlowOCF − Capex | — | $-2.5M |
| FCF MarginFCF / Revenue | — | -19.1% |
| Capex IntensityCapex / Revenue | — | 0.3% |
| Cash ConversionOCF / Net Profit | 4.95× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-19.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $-2.5M | ||
| Q3 25 | $4.9M | $-3.7M | ||
| Q2 25 | $501.0K | $-7.3M | ||
| Q1 25 | $191.0K | $-4.5M | ||
| Q4 24 | $12.9M | $-5.7M | ||
| Q3 24 | $2.3M | $-10.8M | ||
| Q2 24 | $7.0M | $-13.4M | ||
| Q1 24 | $4.2M | $-10.9M |
| Q4 25 | — | $-2.5M | ||
| Q3 25 | — | $-3.9M | ||
| Q2 25 | — | $-7.4M | ||
| Q1 25 | — | $-5.3M | ||
| Q4 24 | — | $-5.8M | ||
| Q3 24 | — | $-11.0M | ||
| Q2 24 | — | $-13.5M | ||
| Q1 24 | — | $-10.9M |
| Q4 25 | — | -19.1% | ||
| Q3 25 | — | -33.9% | ||
| Q2 25 | — | -66.1% | ||
| Q1 25 | — | -57.3% | ||
| Q4 24 | — | -69.7% | ||
| Q3 24 | — | -149.9% | ||
| Q2 24 | — | -183.1% | ||
| Q1 24 | — | -169.3% |
| Q4 25 | — | 0.3% | ||
| Q3 25 | — | 1.9% | ||
| Q2 25 | — | 0.8% | ||
| Q1 25 | — | 8.2% | ||
| Q4 24 | — | 0.6% | ||
| Q3 24 | — | 2.3% | ||
| Q2 24 | — | 0.8% | ||
| Q1 24 | — | 1.0% |
| Q4 25 | — | — | ||
| Q3 25 | 4.95× | — | ||
| Q2 25 | 0.27× | — | ||
| Q1 25 | 0.21× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.90× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
